Physician profile
Sam Lee
NPI 1922779404
$11,020.16
in general payments reported to CMS, 2019-2025
8 companies · $499 in 2025
The $499 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,157 · 2023: $6,475 · 2024: $889 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,200 · Food and Beverage: $1,363 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,200.00 |
| Food and Beverage | $1,363.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $4,430.49 | 2022-2025 | Misight Contact Lens, Clariti Contact Lens, Myday Contact Lens |
| Valley Contax, INC. | $2,655.36 | 2022 | |
| Dompe US, INC. | $2,167.78 | 2023 | Oxervate |
| Alcon Vision LLC | $830.98 | 2022-2025 | Air Optix, Unity |
| Johnson & Johnson Vision Care, INC. | $741.45 | 2022-2025 | Acuvue |
| Aimmune Therapeutics, INC. | $124.98 | 2024 | |
| Visioneering Technologies, INC. | $46.65 | 2024 | |
| Bausch & Lomb Americas INC. | $22.47 | 2023 | Infuse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.